AR022404A1 - METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY - Google Patents

METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY

Info

Publication number
AR022404A1
AR022404A1 ARP000100289A ARP000100289A AR022404A1 AR 022404 A1 AR022404 A1 AR 022404A1 AR P000100289 A ARP000100289 A AR P000100289A AR P000100289 A ARP000100289 A AR P000100289A AR 022404 A1 AR022404 A1 AR 022404A1
Authority
AR
Argentina
Prior art keywords
tissue
agents
radiation therapy
volume
improved radiation
Prior art date
Application number
ARP000100289A
Other languages
Spanish (es)
Original Assignee
Photogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photogen Inc filed Critical Photogen Inc
Publication of AR022404A1 publication Critical patent/AR022404A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

Método para tratar un volumen seleccionado de tejido, método que incluye la distribucion de un radiosensibilizante y una pluralidad de fuentes deradiacion ionizantes sustancialmente dentro del volumen de tejido para producir zonas de tratamiento queestán, en general, uniformemente distribuidas por todoel volumen del tejido. También se incluye un agente para tratar dicho tejido, agente que incluye un radiosensibilizante y una fuente de radiacion ionizanteempleados conjuntamente para definir una gente de tratamiento inyectable.Method for treating a selected volume of tissue, a method that includes the distribution of a radiosensitizer and a plurality of ionizing radiation sources substantially within the volume of tissue to produce treatment areas that are generally uniformly distributed throughout the volume of the tissue. Also included is an agent for treating said tissue, an agent that includes a radiosensitizer and a source of ionizing radiation employed together to define an injectable treatment people.

ARP000100289A 1999-01-25 2000-01-24 METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY AR022404A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23624799A 1999-01-25 1999-01-25

Publications (1)

Publication Number Publication Date
AR022404A1 true AR022404A1 (en) 2002-09-04

Family

ID=22888723

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100289A AR022404A1 (en) 1999-01-25 2000-01-24 METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY

Country Status (10)

Country Link
EP (1) EP1146912A4 (en)
JP (1) JP2002535291A (en)
KR (1) KR20020001723A (en)
CN (1) CN1337886A (en)
AR (1) AR022404A1 (en)
AU (1) AU2972500A (en)
BR (1) BR0007692A (en)
CA (1) CA2358989A1 (en)
IL (1) IL144428A0 (en)
WO (1) WO2000043045A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1601700A (en) * 1998-10-29 2000-05-22 General Hospital Corporation, The Radiodense compositions
US8470296B2 (en) 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US20020001567A1 (en) 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US6818227B1 (en) 1999-02-08 2004-11-16 Alza Corporation Liposome composition and method for administration of a radiosensitizer
HUP0105285A3 (en) * 1999-02-08 2006-07-28 Alza Corp Mountain View Liposome composition and method for its preparation and its use
EP1206288B1 (en) * 1999-08-02 2007-01-10 The Regents Of The University Of Michigan Targeted fiberless radiative effectors
US6746661B2 (en) 2000-11-16 2004-06-08 Microspherix Llc Brachytherapy seed
AU2001297657A1 (en) * 2000-11-16 2002-09-12 Microspherix Llc Polymeric imagable brachytherapy seed
AU2003267309A1 (en) 2000-11-16 2004-04-08 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
AU2004296621A1 (en) * 2003-12-11 2005-06-23 Schering Aktiengesellschaft Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
US8252756B2 (en) 2005-06-14 2012-08-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
JP5512285B2 (en) 2007-02-09 2014-06-04 ノースウェスタン ユニバーシティ Particles for detecting intracellular targets
EP2826863B1 (en) 2007-05-30 2017-08-23 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
KR101525132B1 (en) * 2008-10-08 2015-06-02 포항공과대학교 산학협력단 Capsule of x-ray contrast agent and preparing method thereof
WO2010060110A1 (en) 2008-11-24 2010-05-27 Northwestern University Polyvalent rna-nanoparticle compositions
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
US8269197B2 (en) 2009-07-22 2012-09-18 Intraop Medical Corporation Method and system for electron beam applications
WO2011017456A2 (en) * 2009-08-04 2011-02-10 Northwestern University Localized delivery of nanoparticles for therapeutic and diagnostic applications
KR20120136345A (en) 2009-10-30 2012-12-18 노오쓰웨스턴 유니버시티 Templated nanoconjugates
EA201290846A1 (en) * 2010-03-01 2013-07-30 Интраоп Медикал Корпорейшн RADIOT THERAPY COMBINED WITH HYPOXIC CELL SENSITIZERS
WO2013040499A1 (en) 2011-09-14 2013-03-21 Northwestern University Nanoconjugates able to cross the blood-brain barrier
AU2014292926B2 (en) 2013-07-25 2020-03-05 Exicure Operating Company Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
CA2968531A1 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
WO2016148969A1 (en) * 2015-03-13 2016-09-22 The Board Of Regents Of The University Of Texas System Kub5/hera as a determinant of sensitivity to dna damage
US11433131B2 (en) 2017-05-11 2022-09-06 Northwestern University Adoptive cell therapy using spherical nucleic acids (SNAs)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490543A (en) * 1982-11-12 1984-12-25 University Of Northern Iowa Foundation Low toxicity radiation sensitizer
US5342283A (en) * 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
US6331286B1 (en) * 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions

Also Published As

Publication number Publication date
JP2002535291A (en) 2002-10-22
KR20020001723A (en) 2002-01-09
CN1337886A (en) 2002-02-27
BR0007692A (en) 2001-11-06
WO2000043045A1 (en) 2000-07-27
IL144428A0 (en) 2002-05-23
EP1146912A1 (en) 2001-10-24
CA2358989A1 (en) 2000-07-27
AU2972500A (en) 2000-08-07
EP1146912A4 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
AR022404A1 (en) METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY
BR0115087A (en) Radioactive limb for use in brachytherapy and methods of making a radioactive limb and treating a condition that responds to radiation therapy.
AR021967A1 (en) HIGH ENERGY PHOTOTHERAPEUTIC AGENTS
BR9712599A (en) Processes for the treatment of a particular volume, of cancer and of a volume of cancerous tissue in tissue and for producing at least one photo-active molecular agent in a particular volume of material and apparatus for the treatment of a particular volume of plant tissue or of animals and for the administration of a photo-dynamic medical treatment
ES2179096T3 (en) USE OF INTERLEUCINE-12 TO PREVENT REACTION OF THE GRAFT AGAINST THE GUEST.
BR9911161A (en) Processes for treating a particular volume of plant or animal tissue, for producing at least one photoactivated agent in a particular volume of material, for the medical treatment of a particular volume of tissue, and apparatus for treating a volume plant or animal tissue and, for the administration of a photodynamic medical treatment.
AR021061A1 (en) METHOD FOR PRODUCING IMPROVED IMAGES AND PHOTODYNAMIC THERAPY
IL150725A0 (en) Treatment of congestive heart failure by pretreated autologous blood
AR010259A1 (en) A TREATMENT PROCESS FOR CELLULOSIC FIBERS AND THE MATRIX OBTAINED
ES2064121T3 (en) AGENT TO REDUCE OR ELIMINATE THE GROWTH OF HAIR IN THE HUMAN BODY.
NZ336511A (en) Treating prostatic diseases using delayed and/or sustained release formulations of activated vitamin D
EP1628667A4 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antimitotics
EA200101089A1 (en) NEW METHOD OF TREATMENT
EP1631267A4 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites
AR037346A1 (en) COMBINATION THERAPY
AR004494A1 (en) A CELL USEFUL FOR THE TREATMENT OF PAIN, A METHOD TO PRODUCE IT, A BIOARTIFICIAL ORGAN OF UNDERSTAND IT AND A METHOD TO PREPARE SUCH ORGANOBIOARTIFICIAL
MX2022001450A (en) Method of treating cancer.
DK1077683T3 (en) Antidepressant treatment
MD106C2 (en) Method of treatment for mamma cancer
MX9206135A (en) METHODS
NO984189L (en) Procedure for the treatment of bipolar disorder
ES2152664T3 (en) COMBINATION OF CIS-4-HYDROXY-L-PROLIN AND N-METHYL-C-4-HYDROXY-L-PROLIN FOR APPLICATION AS A THERAPEUTIC AGENT, ESPECIALLY FOR THE TREATMENT AGAINST CANCER.
ATE306278T1 (en) TREATING BONE DISEASES WITH ADRENOMEDULLIN
MX9304878A (en) USE OF A SUBSTITUTED AZASPIRAN IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF PSORIASIS.
NO984198L (en) Procedure for the treatment of aggression